Tech Company Financing Transactions
Asterand Bioscience Funding Round
Arboretum Ventures, Chrysalis Ventures and Fort Washington Capital Partners participated in a $3.5 million funding round for Asterand Bioscience. The round was announced on 6/30/2005.
Transaction Overview
Company Name
Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
440 Burroughs Tech 1 501
Detroit, MI 48202
USA
Detroit, MI 48202
USA
Phone
Website
Email Address
Overview
Asterand Bio is the leading global provider of high quality, well characterized human tissue & tissue-based research solutions to drug discovery scientists.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
John Canepa
VP - Bus. Development
Tony Brown
VP - Human Resources
Pamela Filipowicz
VP - Marketing
Cathie Miller
VP - Operations
Shannon Richey
VP - Operations
Amanda Woodrooffe
Browse more venture capital transactions:
Prev: 6/30/2005: Ooma venture capital transaction
Next: 6/30/2005: Spectrum K12 School Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs